Archivos suplementarios
Palabras clave
Rinitis
Tecnologías de la Información y la Comunicación
Asociación Europea de Innovación para un Envejecimiento Activo y Saludable
Tecnología móvil
Vías de atención integradas para las enfermedades de las vías respiratorias
Cómo citar
Plaudit
Resumen
La iniciativa ARIA (Rinitis Alérgica y su Impacto en el Asma) se inició durante un taller de la Organización Mundial de la Salud en 1999. Los objetivos iniciales fueron proponer una nueva clasificación de rinitis alérgica, promover el concepto de multimorbilidad en asma y rinitis y desarrollar guías con todas las partes interesadas para su en todos los países y poblaciones. ARIA, difundida e implementada en más de 70 naciones, ahora se centra en la implementación de tecnologías emergentes para la medicina individualizada y predictiva. MASK (MACVIA [Contre les Maladies Chroniques pour un Vieillissement Actif] Aria Sentinel Network) utiliza la tecnología móvil para desarrollar vías de atención que permitan el manejo de la rinitis y del asma por un grupo multidisciplinario o por los propios pacientes. Una aplicación (app) para iOS y Android está disponible en 20 países y 15 idiomas; utiliza una escala analógica visual para evaluar el control de los síntomas y la productividad del trabajo, así como un sistema de apoyo para las decisiones clínicas. Se asocia con una tabla interoperable (que permite intercambiar información) para médicos y otros profesionales de la salud. La estrategia de escalamiento utiliza las recomendaciones de la Asociación Europea de Innovación para el Envejecimiento Activo y Saludable. El objetivo del nuevo enfoque ARIA es proporcionar una vida activa y saludable a las personas afectadas por la rinitis, cualquiera que sea su edad, sexo o condición socioeconómica, con el fin de reducir las desigualdades sociales y de salud causadas por la enfermedad.
Referencias
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: Developing guidelines. BMJ. 1999;318(7183):593-596. DOI: http://dx.doi.org/10.1136/bmj.318.7183.593
Bousquet J, Van-Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl 5):147-334. DOI: http://dx.doi.org/10.1067/mai.2001.118891
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8-160. DOI: http://dx.doi.org/10.1111/j.1398-9995.2007.01620.x
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476. DOI: http://dx.doi.org/10.1016/j.jaci.2010.06.047
Padjas A, Kehar R, Aleem S, Mejza F, Bousquet J, Schünemann HJ, et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol. 2014;133(3):777-783. DOI: http://dx.doi.org/10.1016/j.jaci.2013.08.029
Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049-1062. DOI: http://dx.doi.org/10.1016/j.jaci.2012.07.053
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304-323. DOI: http://dx.doi.org/10.1183/09031936.00014614
Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6(1):47. DOI: http://dx.doi.org/10.1186/s13601-016-0137-4
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Iglesia M. The European Innovation Partnership on Active and Healthy Ageing: the European geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361-362. DOI: http://dx.doi.org/10.1016/j.eurger.2014.09.010
Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Augé P, et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax. 2015;70(6):595-597. DOI: http://dx.doi.org/10.1136/thoraxjnl-2014-206304
Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028-1033. DOI: http://dx.doi.org/10.1183/13993003.01856-2015
Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy. 2016;6(1):29. DOI: http://dx.doi.org/10.1186/s13601-016-0116-9
Bousquet J, Bewick M, Cano A, Eklund P, Fico G, Goswami N, et al. Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA. J Nutr Health Aging. 2017;21(1):92-104. DOI: http://dx.doi.org/10.1007/s12603-016-0803-1
Kuehl BL, Abdulnour S, O’Dell M, Kyle TK. Understanding the role of the healthcare professional in patient self-management of allergic rhinitis. SAGE Open Med. 2015;3:2050312115595822. DOI: http://dx.doi.org/10.1177/2050312115595822
Bond C, Bonini S, Bousquet H, Bousquet J, Canonica GW, Howarth P, et al. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59(4):373-387. Disponible en: http://www.progetto-aria.it/materiale/aria_in_the_pharmacy.pdf
Canonica GW, Triggiani M, Senna G. 360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients. Clin Mol Allergy. 2015;13:25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629286/
Meltzer EO, Farrar JR, Sennett C. Findings from an online survey assessing the burden and management of seasonal allergic rhinoconjunctivitis in US patients. J Allergy Clin Immunol Pract. 2017;5(3):779-789. DOI: http://dx.doi.org/10.1016/j.jaip.2016.10.010
Bousquet J, Annesi-Maesano I, Carat F, Léger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005;35(6):728-732. DOI: http://dx.doi.org/10.1111/j.1365-2222.2005.02274.x
Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study. Int Arch Allergy Immunol. 2015;166(3):231-240. DOI: http://dx.doi.org/10.1159/000381339
Del-Cuvillo A, Montoro J, Bartra J, Valero A, Ferrer M, Jauregui I, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients-The ADRIAL cohort study. Rhinology. 2010;48(2):201-205. DOI: http://dx.doi.org/10.4193/Rhin09.099
Calderon MA, Demoly P, Casale T, Akdis CA, Bachert C, Bewick M, et al. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy. 2016;6:41. DOI: http://dx.doi.org/10.1186/s13601-016-0131-x
Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62 Suppl 84:1-41. DOI: http://dx.doi.org/10.1111/j.1398-9995.2007.01551.x
Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study. Int Arch Allergy Immunol. 2015;166(3):231-240. DOI: http://dx.doi.org/10.1159/000381339
Meltzer EO, Wallace D, Dykewicz M, Shneyer L. Minimal Clinically Important Difference (MCID) in allergic rhinitis: Agency for healthcare research and quality or anchor-based thresholds. J Allergy Clin Immunol Pract. 2016;4(4):682-688. DOI: http://dx.doi.org/10.1016/j.jaip.2016.02.006
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel Network for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation. Allergy. 2015;70(11):1372-1392. DOI: http://dx.doi.org/10.1111/all.12686
Bourret R, Bousquet J, Mercier J, Camuzat T, Bedbrook A, Demoly P, et al. MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv. 2015;51(3):36-39.
Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367-374. DOI: http://dx.doi.org/10.1016/j.jaci.2016.03.025
Bousquet J, Caimmi D, Bedbrook A, Bewick M, Hellings P, Devillier P, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72(6):857-865. DOI: http://dx.doi.org/10.1111/all.13125
König HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, et al. Comparison of population health status in six European countries: Results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47(2):255-261. DOI: http://dx.doi.org/10.1097/MLR.0b013e318184759e
Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol. 2001;54(6):610-618. DOI: http://dx.doi.org/10.1016/S0895-4356(00)00349-8
Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009;124(3):428-433. DOI: http://dx.doi.org/10.1016/j.jaci.2009.06.027
Bousquet J, Anto J, Sunyer J, Nieuwenhuijsen M, Vrijheid M, Keil T, et al. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives-a MeDALL, CHICOS, ENRIECO, and GA(2)LEN joint paper. Int Arch Allergy Immunol. 2013;161(1):1-10. DOI: http://dx.doi.org/10.1159/000343018
Westman M, Lupinek C, Bousquet J, Andersson N, Pahr S, Baar A, et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol. 2015;135(5):1199-1206. DOI: http://dx.doi.org/10.1016/j.jaci.2014.10.042
Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, et al. Paving the way of systems biology and precision medicine in allergic diseases: The MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015. Allergy. 2016;71(11):1513-1525. DOI: http://dx.doi.org/10.1111/all.12880
Burte E, Bousquet J, Varraso R, Gormand F, Just J, Matran R, et al. Characterization of rhinitis according to the asthma status in adults using an unsupervised approach in the EGEA Study. PLoS One. 2015;10(8):e0136191. DOI: http://dx.doi.org/10.1371/journal.pone.0136191
Siroux V, Lupinek C, Resch Y, Curin M, Just J, Keil T, et al. Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study. J Allergy Clin Immunol. 2017;139(2):643-654. DOI: http://dx.doi.org/10.1016/j.jaci.2016.05.023
Just J, Elegbede CF, Deschildre A, Bousquet J, Moneret-Vautrin DA, Crepet A, et al. Three peanut-allergic/sensitized phenotypes with gender difference. Clin Exp Allergy. 2016;46(12):1596-1604. DOI: http://dx.doi.org/10.1111/cea.12791
Zoratti EM, Krouse RZ, Babineau DC, Pongracic JA, O’Connor GT, Wood RA, et al. Asthma phenotypes in inner-city children. J Allergy Clin Immunol. 2016;138(4):1016-1029. DOI: http://dx.doi.org/10.1016/j.jaci.2016.06.061
Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107(1):73-80. DOI: http://dx.doi.org/10.1067/mai.2001.111593
Ten-Brinke A, Grootendorst DC, Schmidt JT, De-Bruïne FT, Van-Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109(4):621-626. DOI: http://dx.doi.org/10.1067/mai.2002.122458
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2017 Revista Alergia México